Overview

Ondansetron and Blood Coagulation

Status:
Recruiting
Trial end date:
2020-12-15
Target enrollment:
Participant gender:
Summary
Ondansetron may alter whole blood coagulation. However, little is known about the dose-response relationships according to the blood concentration of ondansetron. The investigators therefore will perform the present study to measure the effect of ondansestron on the blood coagulation pathway according to the drug concentration level using a rotational thromboelastometry test.
Phase:
N/A
Details
Lead Sponsor:
Seoul National University Bundang Hospital
Treatments:
Ondansetron